TMS Co., Ltd. (TYO:4891)
Japan · Delayed Price · Currency is JPY 99.00
0.00 (0.00%)
Aug 6, 2026, 1:41 PM JST
TMS Co., Ltd. Market Cap
TMS Co., Ltd. has a market cap or net worth of 4.51 billion as of August 5, 2026. Its market cap has decreased by -37.15% in one year.
Market Cap
4.51B
Enterprise Value
1.88B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
99.00
ChartMarket Cap Chart
Since November 22, 2022, TMS Co., Ltd.'s market cap has decreased from 28.10B to 4.51B, a decrease of -83.94%. That is a compound annual growth rate of -38.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 4.51B | -23.12% |
| Dec 30, 2025 | 5.87B | -33.26% |
| Dec 30, 2024 | 8.79B | 27.76% |
| Dec 29, 2023 | 6.88B | -69.65% |
| Dec 30, 2022 | 22.68B | -19.29% |
| Nov 22, 2022 | 28.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chordia Therapeutics | 6.10B |
| CellSource | 6.09B |
| Noile-Immune Biotech | 5.99B |
| PRISM BioLab Co.,LTD | 5.77B |
| Soiken Holdings | 5.60B |
| Chiome Bioscience | 5.45B |
| Cyfuse Biomedical K.K. | 5.16B |
| Kohjin Bio | 4.63B |